Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-29 @ 5:45 AM
Study NCT ID:
NCT04950504
Status:
TERMINATED
Last Update Posted:
2023-09-18
First Post:
2021-06-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy
Sponsor:
COUR Pharmaceutical Development Company, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-29
Completion Date Type:
ACTUAL
First Submit Date:
2021-06-03
First Submit QC Date:
None
Study First Post Date:
2021-07-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-14
Last Update Post Date:
2023-09-18
Last Update Post Date Type:
ACTUAL